4.4 Review

Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?

期刊

REPRODUCTIVE TOXICOLOGY
卷 88, 期 -, 页码 67-75

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.reprotox.2019.07.015

关键词

Network; Birth defects; Teratogen STITCH database; Interactome; Congenital anomalies; Malformation; Thalidomide; Zika

资金

  1. INAGEMP (National Institute of Population Medical Genetics) [CNPq573993/2008-4, 465549/2014-4, FAPERGS17/2551.0000521-0]
  2. INAGEMP (National Institute of Population Medical Genetics, CAPES)
  3. National Council of Scientific and Technologic Development (CNPq) [156158/2018-3, 423249/2016-9, 312993/2017-0]

向作者/读者索取更多资源

The recognition of molecular mechanisms of a teratogen can provide insights to understand its embryopathy, and later to plan strategies for the prevention of new exposures. In this context, experimental research is the most invested approach. Despite its relevance, these assays require financial and time investment. Hence, the evaluation of such mechanisms through systems biology rise as an alternative for this conventional methodology. Systems biology is an integrative field that connects experimental and computational analyses, assembling interaction networks between genes, proteins, and even teratogens. It is a valid strategy to generate new hypotheses, that can later be confirmed in experimental assays. Here, we present a literature review of the application of systems biology in embryo development and teratogenesis studies. We provide a glance at the data available in public databases, and evaluate common mechanisms between different teratogens. Finally, we discuss the advantages of using this strategy in future teratogenesis researches.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据